BioNTech SE
Pioneering mRNA immunotherapies and vaccines to combat cancer and infectious diseases.
BNTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US09075V1026
- LEI:
- Country:
- United States of America
- Address:
- AN DER GOLDGRUBE 12, 55131 MAINZ
- Website:
- https://www.biontech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioNTech SE is a next-generation immunotherapy company pioneering the development of novel therapies for cancer, infectious diseases, and other serious conditions. The company's core focus is leveraging the body's immune system to combat disease. Its diverse portfolio includes three primary therapeutic modalities: mRNA-based cancer immunotherapies, which can be individualized for patients; next-generation immunomodulators; and targeted therapies. Building on the success of its mRNA vaccine technology, most notably the COVID-19 vaccine, BioNTech aims to translate its scientific expertise into a broad pipeline of new treatments and vaccines, addressing diseases with high unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioNTech SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioNTech SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioNTech SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
